Table 2 Observed response rates to treatment and outcome of disease
Drug | Number of patients used (%) (n = 131) | Number of patients who responded | Observed response rate (%) |
|---|---|---|---|
NSAIDs | 107 (81.6) | 53/92 | 57.6 |
Bisphosphonates | 89 (67.93) | 61/89a | 68.53 |
55/89b | 61.79 | ||
Methotrexate | 18 (13.74) | 7/16 | 43.75 |
Corticosteroids | 13 (9.92) | 8/10 | 80 |
Adalimumab | 11 (8.39) | 10/11 | 90.9 |
Infliximab | 8 (6.10) | 7/8 | 87.5 |
Sulfasalazine | 3 (2.29) | 2/3 | 66.66 |
Etanercept | 1 (0.76) | 1/1 | 100 |
Mesalazine | 1 (0.76) | 1/1 | 100 |